David Jhonson
The development and validation of screening tools for early detection of Alzheimer’s Disease (AD) are critical for timely intervention and management. This review explores methodologies, challenges and advancements in creating such tools, emphasizing accuracy, sensitivity and practicality in clinical settings. Key considerations include biomarker research, cognitive assessments and machine learning techniques. The discussion encompasses ethical implications and future directions for improving AD screening.
この記事をシェアする
English 
Spanish 
Chinese 
Russian 
German 
French 
Portuguese 
Hindi 